Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis

Figure 10

Validation of the role of BACE1-AS in hepatocellular carcinoma. (a) The combined effect of BACE1-AS and NRP1 on the prognosis of hepatocellular carcinoma. (b) Analysis of survival status and gene expression in high- and low-risk patients. (c) Independent prognostic analysis of the 2-gene signature model risk score. (d) Prognosis difference between high- and low-risk groups of HCC patients. (e) Area under the curve of the risk model at 1, 2, and 3 years. (f) Expression level of BACE1-AS in normal liver cells and liver cancer cells. (g) Evaluation of the effect of risk model on drug sensitivity.

(a)

(b)

(c)

(d)

(e)

(f)

(g)